FT Options »

Teva Pharmaceutical Industries shares owned by FT Options

Quarter-by-quarter ownership of Teva Pharmaceutical Industries (TEVA) shares owned by FT Options from 13F filings

Historical chart of FT Options investment in Teva Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Teva Pharmaceutical Industries held by FT Options consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Teva Pharmaceutical Industries by FT Options

Quarter filed Position value Share count Share price at filing
2017-09-30 $171k 380k 0.45
2016-12-31 $263k 7.3k 36.28
2016-09-30 $4.2M 92k 46.01

More positions owned by FT Options

Incyte Corporation (INCY)
Gilead Sciences (GILD)
Clovis Oncology
iShares NASDAQ Biotechnology Index (IBB)
Insmed (INSM)
Gw Pharmaceuticals Plc ads
Tesaro
Time Warner
Abbvie (ABBV)
General Mills (GIS)
Regeneron Pharmaceuticals (REGN)
Dbv Technologies S A
Kimberly-Clark Corporation (KMB)
Zogenix
Clorox Company (CLX)

View all positions for FT Options

Top funds holding Teva Pharmaceutical Industries

BlackRock
BlackRock
Ion Asset Management
Clal Insurance Enterprises Holdings
Exor Investments
Migdal Insurance & Financial Holdings
Phoenix Holdings
State Street Corporation
Rubric Capital Management
Arrowstreet Capital, Limited Partnership
Slate Path Capital
Morgan Stanley
PointState Capital
Geode Capital Management
Glenview Captal Management

View all funds holding Teva Pharmaceutical Industries